- Home
- » Tags
- » Pralatrexate
Top View
- Clinically Relevant Concentrations of Anticancer Drugs: a Guide for Nonclinical Studies Dane R
- Threshold of Toxicological Concern (TTC) for Anticancer Compounds
- Single Agent and Combination Studies of Pralatrexate and Molecular Correlates of Sensitivity
- Cross Discipline Team Leader Review
- Treatment and Clinical Trials for PTCL
- EMA/PDCO Summary Report on the Review of the List of Granted Class Waivers
- Emetogenic Potential of Antineoplastic Agents
- Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration
- Hazardous Chemical Agents (Anti-Neoplastic, Carcinogens, Reproductive Hazards, Neurotoxic)
- Peripheral T-Cell Lymphoma
- Extract from the Clinical Evaluation Report for Pralatrexate
- Pralatrexate Monograph
- Pralatrexate Injection), for Intravenous Use Hepatic Toxicity: Monitor for Toxicity
- Timing and Characteristics of Cumulative Evidence Available on Novel Therapeutic Agents Receiving Food and Drug Administration Accelerated Approval
- June 30, 2021 Total Approvals 269 This Report Will Be Updated January and July of Every Year
- Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
- [2016]. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016
- FEP 5 Tier Managed Rx Drug Formulary (807) Basic Option
- 2020 Table of Drugs
- Haematology Clinical Guidelines (Lancashire & South Cumbria)
- Characteristics of Non-Randomized Studies Using Comparisons with External Controls Submitted for Regulatory Approval in the Us and Europe: a Systematic Review
- Year of FDA Monthly Cost Approval
- Global Oncology
- Folotyn (Pralatrexate Injection) for the Treatment of Patients with Relapsed Or Refractory Peripheral T-Cell Lymphoma: U.S
- (CE-Melphalan), at the Annual Meeting of the American Pharmacists Association (Apha) in San Diego, Highlighting Stability
- Do Not Tube List
- Australian Public Assessment for Pralatrexate
- FDA and ISMP Lists of Look-Alike Drug Names with Recommended Tall Man Letters
- Pralatrexate
- Hazardous Drug List
- Overview of Dual-Acting Drug Methotrexate in Different
- Managing Pharmacotherapy in People Living with HIV And
- BC CANCER CHEMOTHERAPY PREPARATION and STABILITY CHART DRUG & STRENGTH (Storage Prior to Use, Manufacturer, Preservative
- Supplementary Online Content
- Chemotherapeutic Drugs in Lebanese Surface Waters: Estimation of Population Exposure and Identifcation of High-Risk Drugs